No savings at 50? I’d buy these 2 FTSE 100 income stocks over a buy-to-let

Harvey Jones says FTSE 100 (INDEXFTSE:UKX) shares beat property on ease, income and tax grounds.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Investing in a buy-to-let property used to be a great way of generating extra income in retirement, but it’s not so tempting now.

Higher rate mortgage tax relief is being phased out, while investors must also pay a 3% stamp duty surcharge on purchases. As if that wasn’t enough, landlord ‘wear and tear’ allowances have been cut back as well.

Personally, I’d rather invest in FTSE 100 stocks, which also give you a winning combination of capital growth and income, but with a lot less bother. Also, if you buy inside your Stocks and Shares ISA allowance, you will not have to pay a penny of tax on your gains. Here are two to consider.

HSBC Holdings

One stock I would consider is global bank HSBC Holdings (LSE: HSBA). This is the third-largest company in the UK, after Royal Dutch Shell and Unilever, with a market cap of a massive £116bn. The group generates more than 90% of its earnings from China and Hong Kong, which exposes you to the greater growth potential of fast-growing emerging markets, but with the superior corporate governance you get from a London listing.

The bank isn’t without its risks, though, so make sure you understand those. For example, the HSBC share price has fallen around 12% over the last year, as the Chinese economy has been hit by US trade wars, while the political turmoil in Hong Kong hasn’t helped.

However, recent underperformance has made today’s entry price look tempting, as it now trades at just 10.4 times forward earnings, far cheaper than the average ratio for the index of around 17 times earning. Its price-to-book ratio is 0.8, comfortably below the 1.0 usually seen as representing fair value.

HSBC is now restructuring in a bid to increase its return on capital, and the cost-cutting operation should further drive shareholder value. This is a terrific income stock, with a forecast yield of 7%, far higher than you will earn in rent on most buy-to-let properties. Hong Kong remains a worry, so take a view on that risk before you buy.

Legal & General Group

I have regularly tipped FTSE 100-listed insurer and asset manager Legal & General Group (LSE: LGEN), and now appears to be justifying my faith in it. The L&G share price is up almost 25% this year, but still trades at a dirt-cheap valuation of just 8.8 times forward earnings.

The £16bn group offers a wide range of financial services, including investment management, lifetime mortgages, pensions, annuities, life assurance, and general insurance, and will benefit from the trend for people to make more provision for their future.

It is a major asset manager with more than £1trn of assets, and a UK leader in bulk annuities and life insurance. Over the last 10 years, it has delivered a total shareholder return of 404%, with dividends invested, outstripping the FTSE Life index at 182%.

Legal & General has delivered regular dividend growth in recent years and now offers a secure yield of 6.2%, healthily covered 1.9 times by earnings. Again, that’s more than you will get on many buy-to-let properties, and with a lot less tax and trouble.

Harvey Jones has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended Unilever. The Motley Fool UK has recommended HSBC Holdings. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »